Post-translational modifications such as phosphorylation and palmitoylation play important roles for the function and regulation of receptors coupled to heterotrimeric guanyl nucleotide-binding proteins. Here we demonstrate that the human endothelin receptor A (ET A ) incorporates [ 3 H]palmitate. Mutation of a cluster of five cysteine residues present in the cytoplasmic tail of ET A into serine or alanine residues completely prevented palmitoylation of the receptor. The ligand binding affinity of the non-palmitoylated ET A mutants was essentially unchanged as compared to the palmitoylated wild type ET A suggesting that the replacement of the cysteine residues did not alter the overall structure of the receptor. Furthermore, the ligand-induced stimulation of adenylyl cyclase by the mutant ET A was unaffected by the mutation. In contrast, the mutated nonpalmitoylated receptors but not the wild type receptor failed to stimulate phosphatidylinositol hydrolysis by phospholipase C activation upon challenge by endothelin-1. Furthermore, the mutant receptors failed to stimulate the ligand-induced transient increase in the cytoplasmic calcium seen with the wild type ET A . Endothelin-1 induced mitogenic stimuli via the wild type receptors but not through the mutated receptors suggesting an important role for phospholipase C in this signal transduction pathway. The differential regulation of distinct signal transduction pathways by posttranslational modification suggests that palmitoylation of the ET A provides a novel mechanism of modulating ET A receptor activity.
Post-translational modifications such as phosphorylation and palmitoylation play important roles for the function and regulation of receptors coupled to heterotrimeric guanyl nucleotide-binding proteins. Here we demonstrate that the human endothelin receptor A (ET A ) incorporates [ 3 H]palmitate. Mutation of a cluster of five cysteine residues present in the cytoplasmic tail of ET A into serine or alanine residues completely prevented palmitoylation of the receptor. The ligand binding affinity of the non-palmitoylated ET A mutants was essentially unchanged as compared to the palmitoylated wild type ET A suggesting that the replacement of the cysteine residues did not alter the overall structure of the receptor. Furthermore, the ligand-induced stimulation of adenylyl cyclase by the mutant ET A was unaffected by the mutation. In contrast, the mutated nonpalmitoylated receptors but not the wild type receptor failed to stimulate phosphatidylinositol hydrolysis by phospholipase C activation upon challenge by endothelin-1. Furthermore, the mutant receptors failed to stimulate the ligand-induced transient increase in the cytoplasmic calcium seen with the wild type ET A . Endothelin-1 induced mitogenic stimuli via the wild type receptors but not through the mutated receptors suggesting an important role for phospholipase C in this signal transduction pathway. The differential regulation of distinct signal transduction pathways by posttranslational modification suggests that palmitoylation of the ET A provides a novel mechanism of modulating ET A receptor activity.
Post-translational modifications of receptors coupled to heterotrimeric guanyl nucleotide-binding proteins (G protein) modulate receptor function and activity (1) (2) (3) . One such modification is the palmitoylation of conserved cysteine residues located in the cytoplasmic tail of many G protein-coupled receptors. It has been suggested that this acylation provides a membrane anchor that creates a fourth cytoplasmic receptor loop (4, 5) . The functional role of palmitoylation has been studied for adrenergic receptors in some detail. Prevention of palmitoylation of a conserved cysteine residue, Cys 341 , of the ␤-adrenergic receptor causes functional uncoupling of the receptor from the adenylyl cyclase pathway (4) . Furthermore, the nonpalmitoylated receptor shows an increased basal phosphorylation and a rapid desensitization in response to its ligand (6) . Activation of the ␤ 2 -adrenergic receptor results in an enhanced palmitoylation thereby increasing the amount of functionally coupled receptor (7) . Adrenergic receptor activation also increases palmitoylation of a receptor-associated stimulatory G protein (8) . These findings clearly show the dynamic properties of protein/receptor palmitoylation. Unlike the ␤ 2 -adrenergic receptor a mutation of the corresponding palmitoylation site in the ␣ 2A -adrenergic receptor did not influence the signal transduction activity but decreased the ligand-promoted down-regulation of the receptor (9) . On the other hand, purified nonpalmitoylated bovine rhodopsin shows an increased signal transduction activity compared to the palmitoylated receptor as evidenced by the increase in transducin activity (10) . The reported pleiotropic effects of palmitoylation on receptor activity raise the question of how this post-translational modification will influence the signal transduction activity of other G protein-coupled receptors, especially of those that stimulate multiple signal transduction pathways such as the phospholipase C (PLC) 1 and the adenylyl cyclase pathways by coupling to different G proteins within the same cell.
Endothelins, a family of three closely related peptide hormones, endothelin-1, -2, and -3 (ET-1, ET-2, and ET-3) (11-13) mediate their multiple biological effects by at least two types of receptors, endothelin receptor A (ET A ) (14) and endothelin receptor B (ET B ) (15) . The ET receptors belong to the large receptor family characterized by seven transmembrane-spanning regions which regulate distinct intracellular signaling pathways through the activation of G proteins. Stimulation of ET A expressed in CHO cells revealed a ligand-dependent increase in cAMP formation via G␣ s whereas activation of ET B expressed in the same cell type inhibited forskolin-stimulated cAMP synthesis via G␣ i (16, 17) . Ligand-activated ET A and ET B both stimulate phosphatidylinositol hydrolysis, most likely via a pertussis toxin insensitive G protein such as Gq. In addition, ET A and ET B stimulate release of arachidonic acid and exhibit mitogenic activity. Whether these latter effects are indirectly produced by the increase in cytoplasmic Ca 2ϩ ([Ca 2ϩ ] i ) and/or by the modulation of cAMP formation, or whether they are due to direct activation of effector enzymes by ET A and ET B is unclear.
In the present study we provide experimental evidence for a functional role of palmitoylation in the modulation of signal transduction activity of the human ET A . We demonstrate that the mutated non-palmitoylated ET A receptor has lost its ability to stimulate phosphatidylinositol hydrolysis while its capacity to stimulate cAMP formation is unchanged. The activated nonpalmitoylated ET A failed to stimulate the release of arachidonic acid and showed no mitogenic activity. The differential modulation of signal transduction pathways might indicate that activation of adenylyl cyclase and of phospholipase C by ET A are two independently controlled processes that could be regulated by receptor palmitoylation. Cloning of the ET A Receptor-The nucleotide sequence encoding the ET A receptor was amplified by the polymerase chain reaction using human placenta cDNA as a template together with the following primers: T4 (5Ј-CCGACCCGGAGCTGTCTG-3Ј) and T5 (5Ј-ATTTCTTCTT-GGGTGTGGGA-3Ј). The 1,400-base pair fragment that was specifically amplified was subcloned into the EcoRV-/SmaI sites of Bluescript KS ϩ (Bks ϩ ) and also into the SmaI site of pVL-1392. Individual clones were isolated, and the nucleotide sequence of the ET A receptor was verified by the Sanger sequencing method.
EXPERIMENTAL PROCEDURES

Materials-Materials
Mutagenesis of the ET A Receptor cDNA-The ET A receptor cDNA excised from Bks ϩ was subcloned into pcDNAIII using XbaI/ApaI restriction sites. This construct was used as the template for the polymerase chain reaction-based site-directed mutagenesis according to standard procedures. The following primers were used: two ET A receptor cDNA flanking primers P1 (5Ј-GCCTCACCATGGAAACCCTTT-GCC-3Ј) and P2 (5Ј-CCTCAAATTTGCCTCTAGATGGAAACCCTTT-CCCTCAGGGCATCC-3Ј); the ET A -specific mutation primers Mser (CCCTCTCCTCCTCCATTACCAGTCC-3Ј) to mutate a cluster of 5 cysteine residues to serine (ET A -1215S) and Mala (5Ј-CCAGTCAGC-CCTCGCCGCCGCCGCCTACCAGTCCAAAAGTC-3Ј) for the mutation of the same cysteine into alanine residues (ET A -1215A). The identity of the mutations was verified by sequence analysis. The cDNA fragments containing the mutated ET A -1215S or ET A -1215A gene were subcloned into the EcoRV/XbaI restriction sites of pcDNAIII and in the SmaI/XbaI restriction sites of pVL1393.
Cell Culture-CHO-K1 were grown in Dulbecco's modified Eagle's medium supplemented with Ham's F-12 nutrient mixture supplemented with 10% fetal calf serum (FCS) and 0.5% penicillin/streptomycin in a humidified CO 2 -atmosphere at 37°C. COS7 cells were kept under the same conditions except that RPMI medium was used. Insect (Sf9) cells were cultured as monolayers in TC100 medium supplemented with an additional 10% FCS, 0.5% penicillin/streptomycin in a normal atmosphere at 27°C (18) .
Transfection of CHO-K1 and COS7 Cells-The CHO-K1 cells were transfected with the pcDNAIII constructs of (mutated) ET A by the calcium phosphate method (19) . Transfectants were isolated by single cell cloning under selection with 500 g/ml G418 for 3 weeks and analyzed for their specific binding of [
125 I]ET-1. COS7 cells were transfected with recombinant pcDNAIII constructs together with a ␤-galactosidase expression plasmid for determination of transfection efficiency (20) using the calcium phosphate method (19) . After 72 h the transfected cells were used for functional assays.
Cloning of Recombinant Baculovirus and Infection of Sf9 CellsRecombinant baculoviruses were generated by cotransfection of Sf9 cells in 60-mm dishes with the pVL1392/3 constructs and with linearized Autographa californica nuclear polyhedrosis virus DNA by the lipofection method following the instructions of the manufacturer (Invitrogen). Two days after lipofection fresh Sf9 cells were infected with varying dilutions (10 Ϫ3 to 10 Ϫ6 ) of harvested medium in 96-well plates to isolate positive viral clones. Subcloned recombinant viruses were identified by their ability to direct expression of the appropriate protein as revealed by immunoblotting. Sf9 cells were infected with recombinant baculovirus at a multiplicity of infection of 2 to 5. For immunoprecipitation the cells were harvested 72 h after infection, and for cAMP and fura-2 assays after 12 to 18 h.
Radioligand Binding to Intact Cells-Radioligand binding assays were conducted as described (21) with minor modifications. Briefly, clonal CHO-K1 and transfected COS7 cells were grown in 96-well plates, rinsed three times with 0.15 M NaCl, 0.1 M phosphate, pH 7.4 (PBS), and incubated under gentle agitation for 4 h at 4°C in 50 l of the assay buffer (PBS, 0.5% bovine serum albumin, 0.26 g of ␣-glucose/ 100 ml) containing [
125 I]ET-1 (50 pM, 2000 Ci/mmol) and competing peptides in the indicated concentrations. After three rapid washes with 100 l each of ice-cold PBS, the cells were solubilized with 0.5 N NaOH, 1% SDS, and the amount of bound [
125 I]ET-1 was determined by ␥-counting. Sf9 cells infected for 12 h were washed three times with PBS, collected by centrifugation (1,500 ϫ g for 10 min at 20°C), resuspended in assay buffer, and incubated for 12 h at 4°C. Bound ligand was separated from free ligand by filtration over Whatman 6F/C filters followed by three washes with PBS. Filter-bound radioactivity was measured in a ␥-counter.
Determination of Whole Cell cAMP Formation-CHO-K1, COS7, and Sf9 cells expressing wild type ET A or mutants ET A -1215S/A were cultured in 24-well plates before incubation with 300 l/well of medium containing 1.5 mM isobutylmethylxanthin for 10 min. The cells were stimulated for 15 min in the same medium with varying concentrations of ET-1 as indicated. The reactions were stopped by aspiration of the medium followed by the addition of 500 l/well of ice-cold 50 mM Tris-HCl, pH 8.0, containing 4 mM EDTA. Cells were scraped into a reaction tube, boiled for 3 min, and centrifuged (14,000 ϫ g for 3 min at 4°C). The supernatants were assayed for cAMP using a [
3 H]cAMP competition binding kit according to the manufacturers instructions.
Determination of Inositol Phosphate-Inositol trisphosphate hydrolysis was measured using a modified procedure described recently (22) . Briefly, clonal CHO-K1 cells were grown to confluence in 24-well plates and labeled with myo- [2- 3 H]inositol (1 Ci/ml) for 12 h in serum-free medium (116 mM NaCl, 5.3 mM KCl, 0.81 mM MgSO 4 ϫ 7 H 2 O, 1 mM CaCl 2 , 5 mM ␣-glucose, 20 mM Hepes, 1 ϫ minimum essential medium amino acids, pH 7.4). Following incubation with 10 mM LiCl for 15 min the cells were directly stimulated at 37°C in this medium with varying concentrations of ET-1 as indicated. The reactions were stopped after 10 min by aspiration of the medium and addition of 1 ml of ice-cold formic acid (10 mM, pH 3). After incubation for 30 min at 4°C these supernatants were mixed into 3 ml of 50 mM ammonia solution (final pH Ͼ 9), and these extracts were applied to anion exchange columns prepared with 0.3 to 0.5 g of Dowex AG:1-8x where the hydroxide form had been exchanged to the formate form as described by the manufacturer (BioRad). Columns were eluted with 10 ml of H 2 O to remove free inositol, followed by 2 ml of 2 M ammonium formate/formic acid, pH 5.2, to elute total inositol phosphates. The eluates were quantified by liquid scintillation counting.
[Ca 2ϩ ] i Measurement by Fura-2/AM-Intracellular Ca 2ϩ concentrations were determined by the fluorescent Ca 2ϩ chelating agent, fura-2/ AM. Clonal CHO-K1 cells confluently cultured on glass coverslips, and aliquots of a Sf9 cell suspension were incubated with loading solution (116 mM NaCl, 5.3 mM KCl, 0.81 mM MgSO 4 ϫ 7 H 2 O, 1 mM CaCl 2 , 20 mM HEPES, minimal essential medium amino acids, pH 7.4) for 30 min at 37°C (CHO) or for 1.5 h at room temperature (Sf9). The incubation was followed by two washes with loading solution containing 5 mM ␣-glucose. Loaded cells were stimulated with different concentrations of ET-1 as indicated, and the fluorescence emission was recorded using a HITACHI spectrophotometer. To test for the PLC activity of clonal CHO-K1 cells previously challenged with ET-1, the cells were stimulated with 4 mM ATP. To investigate the involvement of PLC in the transient increase in [Ca 2ϩ ] i , Sf9 cells were incubated with 4 M U73122, a specific PLC inhibitor, or with 10 M LaCl 3 , an inhibitor of Ca 2ϩ channel opening, prior to stimulation with 100 nM ET-1. Fluorescence monitoring, calibration procedures, and all other experimental details were as described (23, 24) .
Determination of [ (25, 27) . Clonal CHO-K1 cells were grown in 24-well plates for 48 h. At a confluence of 70% the cell cultures were synchronized for 24 h in serum-free Ham's, then stimulated for 18 h with varying concentrations of ET-1 in serum-free medium as indicated, followed by an incubation for 4 h in fresh serum-free medium containing [ 3 H]thymidine (1 Ci/ml) and different concentrations of ET-1. After washing three times with ice-cold PBS the cells were treated with 10% trichloroacetic acid for 30 min at 4°C, followed by another wash with ice-cold PBS. Acidinsoluble fractions were solubilized with 0.1 N NaOH, 1% SDS for 30 min at 37°C, and the associated radioactivity was quantified by liquid scintillation counting.
Gel Electrophoresis and Immunoblotting-After 48 -72 h of infection the Sf9 cells were washed three times with PBS and resuspended in sample buffer (63 mM Tris-HCl, pH 6.8, containing 2.5% SDS, 5% glycerol, 5% ␤-mercaptoethanol, 0.005% bromphenol blue) and incubated for 30 min at 42°C. SDS-polyacrylamide electrophoresis (SDS-PAGE) was carried out in 10% acrylamide gels. Gels were processed for immunoblotting as described the manufacturer's instructions ("Westran," Schleicher & Schuell). All antisera were used at a 1:2.500 dilution. Anti-rabbit IgG conjugated to horseradish peroxidase and the chemiluminescence detection method were employed for visualization of the protein bands.
Immunoprecipitation of ET A -Sf9 cells that had been infected for 60 h were washed twice with ice-cold PBS and resuspended in ice-cold RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, containing 0.1% SDS, 0.5% deoxycholat, 1% Nonidet P-40) with rotation for 1 h at 4°C. The cell lysates were centrifuged at 14,000 ϫ g for 10 min at 4°C and the supernatants incubated under rotation for 1 h at 4°C with specific antibodies previously coupled to staphylococcus A. The reactions were terminated by centrifugation (8,000 ϫ g for 2 min at 4°C). The pellets were washed twice with ice-cold RIPA buffer and resuspended in 30 l of sample buffer (250 mM Tris-HCl, pH 6.8, containing 4% SDS, 20% glycerol, 10% ␤-mercaptoethanol, 0.002% bromphenol blue) and incubated with 20 l of 10 M uretic acid for 30 min at 42°C.
Palmitoylation of ET A in Sf9 Cells-After 48 h of infection the Sf9 cells were washed twice with serum-free TC100 medium and cultured in serum-free TC100 medium for 12 h. Following this period the cells were placed in fresh serum-free TC100 medium and metabolically labeled with [9, H]palmitic acid (0.2 mCi/ml) for 4 h at 27°C. The reaction was stopped by washing the cells twice with ice-cold PBS. Receptor solubilization and immunoprecipitation were carried out as described above. Reducing SDS-PAGE was performed with the immunoprecipitated samples using 10% acrylamide gels including 1 M urea. The gels were fixed with methanol/H 2 O/acetic acid (10:77.5:12.5) and incubated in H 2 O for 45 min at room temperature. Following another incubation with 15% (w/v) sodium salicylate for 30 min at room temperature, the gels were dried for 2 h at 60°C and exposed to Fuji films for 1 week at Ϫ70°C.
Metabolic Labeling with 35 S-Amino Acids-Infected Sf9 cells were washed once with cysteine/methionine-free IPL41-medium without serum. Following incubation in the same medium for 30 min the cells were metabolically labeled with 50 Ci/ml each of [ 35 S]cysteine/methionine for 6 h at 27°C, followed by ET A receptor solubilization, immunoprecipitation, and SDS-PAGE as described above. The gels were fixed with methanol/H 2 O/acetic acid (10:77.5:12.5), dried for 2 h at 60°C, and exposed to a Fuji x-ray film for 8 h at Ϫ70°C. ] i via activation of PLC (Fig. 1B) . The recombinant ET A is also functionally coupled to adenylyl cyclase. A dose-response curve of ET-1-mediated cAMP release revealed an EC 50 of 3.4 nM (Fig. 2B) . Hence the ET A recombinant receptor expressed in Sf9 cells exhibits high affinity binding of the cognate ligand and functional coupling both to the PLC and adenylyl cyclase signal transduction pathways.
RESULTS
Functional Expression of the ET
Detection of the ET A by Anti-peptide Antibodies-To examine post-translational modifications of the human ET A receptor, antibodies against five synthetic peptides from the extracellular and intracellular domains of the receptor were generated in rabbits (Table II) . The titers of specific antibodies were similar for the various peptides as judged by indirect enzyme-linked immunosorbent assay using titer plates coated with the cognate peptides. Only antisera directed against the amino-terminal (␣-CDN25) or the carboxyl-terminal (␣-CTS24) region of the receptor cross-reacted with the ET A protein in Western blotting and immunoprecipitations. Identical cross-reactivity profiles were obtained with anti-peptide antisera raised in mice (not shown).
For immunoprecipitations human ET A was expressed in Sf9 cells that had been metabolically labeled with [ 35 S]cysteine/ methionine. The total cell lysates were immunoprecipitated with the combined antisera ␣-CDN25 and ␣-CTS24 and subjected to SDS-PAGE. Two distinct bands, a major band of approximately 48 kDa and a minor band of 38 kDa were immunoprecipitated by the antisera (Fig. 3A) . In addition a band of 96 kDa was detected that might represent a dimerized receptor. No specific bands were found in immunoprecipitates of (Fig. 3, B and C) (Fig. 3A) . The incorporated [ 3 H]palmitate was released upon incubation of the immunoprecipitated receptor protein with 1 M hydroxylamine, pH 7.0, prior to SDS-PAGE whereas treatment with 1 M Tris-HCl, pH 7.0, showed no effect (Fig. 3C) ) in the corresponding region (Fig. 4) . Replacement of this cluster by five serine residues using polymerase chain reaction-based site-directed mutagenesis generated a mutated ET A receptor, ET A -1215S (Fig. 4) . The exchange of the cysteine residues resulted in the elimination of a detectable incorporation of [ (Fig. 3B) . While the replacement of the cysteine residues abolished the [ 3 H]palmitate incorporation into ET A -1215S the expression levels of the wild type and mutant ET A receptor protein were similar: immunoprecipitation of 35 S-labeled wild type ET A or ET A -1215S protein demonstrated similar expression levels of the two receptor variants (Fig. 3D) . Replacement of the five cysteine residues with alanine ("ET A -1215A") gave comparable results, i.e. lack of palmi- 
Effect of Cysteine Replacement on the Binding Properties of ET A -
The availability of the palmitoylated (wild type ET A ) and non-palmitoylated receptor variants (ET A -1215S and ET A -1215A) gave us the opportunity to assess the functional role of palmitoylation, e.g. for phospholipase C activation, arachidonic acid release, and mitogenic activity. Because Sf9 cells are not suitable for all these functional assays we choose to stably transfect CHO cells with the wild type ET A or the mutant ET A -1215S cDNA, and used these transfectants for functional assays.
To determine the binding properties of the non-palmitoylated ET A -1215S and ET A -1215A, we performed competition binding experiments of [ (Table I) . In Sf9 cells, the IC 50 values for ET-1 were 29.3 nM for the wild type ET A , 1.9 nM ET-1 for ET A -1215S, and 0.6 nM ET-1 for ET A -1215A. In CHO cells the corresponding IC 50 values were 1.1 nM for the wild type ET A and 2.4 nM for ET A -1215S (mean of three independent CHO clones). In conclusion the non-palmitoylated ET A receptor mutants had similar or even slightly increased binding affinities for their cognate ligand, ET-1, confirming the integrity of their overall structure. [Ca 2ϩ ] i and Phosphatidylinositol Hydrolysis by ET A -Next we compared the signal transduction properties of ET A -1215S to the wild type ET A . In CHO cells the dose-response curve of the ET-1-stimulated increase of inositol phosphates revealed an EC 50 of 10.8 Ϯ 5.1 nM ET-1 for the wild type ET A , whereas three independent CHO clones expressing ET A -1215S failed to show a ligand-dependent increase in phosphatidylinositol hydrolysis (Fig. 5) . This lack of stimulation of phosphatidylinositol hydrolysis by ET A -1215S indicates that the mutant ET A -1215S receptor has lost the ability to stimulate PLC. This hypothesis is supported by the finding that ET A -1215S also failed to increase [Ca 2ϩ ] i upon challenge with ET-1 in Sf9 cells: using fura-2/AM to analyze [Ca 2ϩ ] i changes we were able to show a ligand-dependent transient in [Ca 2ϩ ] i only for the wild type ET A (Fig. 1A) but not for ET A -1215S (Fig. 1C) or ET A -1215A (Fig. 1D) . Similar results were obtained with three independent CHO cell clones stably expressing the ET A -1215S receptor (Fig. 6) . Because the specific PLC inhibitor, U73122, completely blocked the ET-1-induced [Ca 2ϩ ] i increase mediated by the wild type ET A (Fig. 1B) , we conclude that the non-palmitoylated ET A mutants have lost their ability to stimulate PLC and consequently to increase [Ca 2ϩ ] i in CHO and Sf9 cells.
Effect of Cysteine Replacement on the Regulation of
Effect of Cysteine Replacement on the Stimulation of cAMP Synthesis by ET A -
The failure of ET A -1215S/A to stimulate phosphatidylinositol hydrolysis and to increase [Ca 2ϩ ] i might suggest that the replacement of the cysteine cluster had generated a functionally deficient mutant of ET A . However, CHO cells stably expressing wild type or mutant ET A showed no apparent differences in the ET-1-induced increase of cAMP synthesis. The EC 50 values calculated from the dose-response curves of cAMP stimulation were 12.9 nM ET-1 for the wild type ET A ( Fig. 2A) and 6.3 nM ET-1 (Fig. 2C) d Peptide names are composed by the first three amino terminal residues using the one letter code, followed by the total number of residues of the peptide.
ET A -1215S clone (Table I ). The maximum stimulation of cAMP synthesis was about 10-fold for the wild type ET A ( Fig. 2A) and 2.5-to 7-fold for the various ET A -1215S clones (Fig. 2C) . The capacity of ET A -1215S to stimulate cAMP formation was confirmed with Sf9 cells (Fig. 2D) where EC 50 values of 3.4 nM ET-1 for the wild type ET A and of 4.1 nM ET-1 for ET A -1215S were found (Table I ). In addition, the efficacy values were similar for the wild type and the mutated receptors: maximum stimulation of cAMP synthesis was 2-fold in the case of the wild type ET A and 2.3-fold for ET A -1215S (Fig. 2, B and D) . We conclude that the non-palmitoylated ET A has selectively lost its capacity to stimulate the phospholipase C pathway but retained its capacity to activate the adenylyl cyclase pathway. Endothelins have powerful mitogenic effects through the ET A receptor. These mitogenic effects are thought to be due to ET A -mediated PLC activation giving rise to diacylglycerol and inositol triphosphate formation, with subsequent activation of protein kinase C (PKC) by diacylglycerol and the inositol triphosphate-triggered increase of [Ca 2ϩ ] i . To test this hypothesis we measured ET-1-induced [ (Fig. 8) . Therefore the ligand-induced activation of PLC seems to be necessary for the ET A -mediated mitogenic stimuli, and cAMP formation alone is not sufficient to promote these effects. Hence abrogation of palmitoylation due to the mutation of a critical cysteine cluster renders the ET A receptor non-mitogenic. DISCUSSION We have demonstrated that the human ET A is covalently modified by thioesterification of palmitic acid. Replacement of cysteine residue cluster in the carboxyl terminus by serine or alanine residues results in a non-palmitoylated ET A that is still able to stimulate adenylyl cyclase but has lost its ability to stimulate PLC, to increase [Ca 2ϩ ] i , to release arachidonic acid, and to mediate ET-1-induced mitogenic effects. Thus, palmitoylation appears to differentially modulate the ET A signal transduction activity.
Effect of Cysteine Replacement on [ 3 H]Arachidonic Acid Release and Mitogenic Activity of ET A -ET
The similar expression levels of wild type ET A and ET A -1215S/A suggest that post-translational modification of the receptor by palmitoylation is not essential for the expression and processing of ET A . High affinity binding of ET-1 by the mutant receptors is a good indication that the overall structure of the receptor has not been changed by the amino acid replacement. These data are in line with the findings of unchanged binding properties for the non-palmitoylated ␣ 2 -adrenergic receptor (28) and the rat lutropin/choriogonadotropin receptor (29) . The available data do not strictly prove that loss of palmitoylation and the functional impairment of ET A are causally related. It is still possible that the replacement of the cysteine residue cluster alone causes the loss of function in the ET A mutants, and that lack of palmitoylation is only an epiphenomenon. It is also conceivable that the mutations impair the palmitoylation of ectopical cysteine residues. For example, Hepler et al. (30) have shown by enzymatic deacylation of critical cysteine residues that palmitoylation of G␣ q is not required for activation of PLC␤1, G␣ q and m 1 -muscarinic receptor, rather that the cysteine residues are functionally important per se, and their palmitoylation might even have an inhibitory effect on G protein function. However, other reports where the corresponding cysteine residues of G␣ q had been mutated to serine residues came to the conclusion that palmitoylation is essential for G␣ q function (31, 32) . Few such data are available for G protein-coupled receptors: depalmitoylation of purified rhodopsin results in an enhanced light-dependent GTPase activity (33) . Therefore, the comparing study of the functional properties of palmitoylated and non-palmitoylated cysteine residues in the terminal domain of ET A will await the purification of the wild type ET A and its chemical or enzymatic deacylation.
The finding that ET A -1215S stimulates adenylyl cyclase without activating PLC cannot simply be explained by differences in the receptor efficacy: even at ET-1 concentrations that were Ͼ1000-fold above those necessary for the wild type ET A the mutant ET A -1215S/A receptor failed to activate PLC. This data suggests that the ET A -1215 mutant has essentially lost its capability to stimulate PLC. On the other hand the minor differences seen in the stimulation of cAMP synthesis of randomly picked CHO clones expressing ET A -1215S are likely to reflect variable efficacy. In Sf9 cells where clonal variation does not occur the same mutant receptor had an EC 50 for ET- The selective impairment of signal transduction properties has been previously reported for thyrotropin receptor (35) and for the neurotensin receptor (36) where mutations were introduced into the third cytoplasmic loop (ED4) without affecting post-translational modifications of these receptors. These findings are in agreement with our observation that distinct structural elements of G protein-coupled receptors appear to be involved in the coupling to the various signal transduction pathways. The novelty of the our present study lies in the discovery of a differential modulation of signal transduction by a post-translational modification, and in the identification of a cysteine residue cluster located in the tail domain, ED4, of the receptors that seems to be essential for PLC activation by ET A . The specific role of ED4 in signal transduction is highlighted by a recent report that carboxyl-terminal truncations of the ET A protein abolished its capacity to modulate [Ca 2ϩ ] i (17) , however, no information was provided regarding whether the mutant receptors stimulate phosphatidylinositol hydrolysis or activate cAMP synthesis.
The differential coupling of ET A -1215S provides a novel mechanism of receptor modulation by post-translational modification. Whereas the dynamic turnover of palmitate has been shown for several proteins including G protein-coupled receptors (8, 37, 38) , we could not demonstrate such a ligand-dependent modulation of ET A palmitoylation in Sf9 cells. Agoniststimulated increase in receptor palmitoylation has been shown for the ␤2-adrenergic receptor (2) where a 2-fold up-regulation of palmitoylation was seen under certain experimental conditions. We have been unable to find such a ligand-dependent modulation for the ET A receptor. Therefore we conclude that ET A palmitoylation is not regulated by the cognate agonist, however, it may vary depending on the cell type and/or the differentiation status of a given cell.
An obvious explanation for the failure of ET A -1215S/A to stimulate PLC might be its inability to bind G␣ q protein; in our experiments we have not directly addressed this possibility (see below). However, in the case of the homologous ␤ 2 -adrenergic receptor the lower affinity of the non-palmitoylated receptor compared to the wild type receptor suggests that G␣ s binding is impaired in the mutant receptor (4) . Because ET A does not seem to be coupled to a G protein prior to ET-1 binding (39) we can only speculate that the non-palmitoylated ET A is unable to bind G␣ q . Alternatively the ligand-activated ET A receptor mutants could bind to G␣ q but their ability to stimulate the conformational change of G␣ q necessary to induce the GTP/GDP exchange might be impaired (40). The latter possibility would then suggest that two different active states of ligand-activated ET A are necessary for G␣ s versus G␣ q activation. At present we cannot discriminate between these possibilities.
The ET A mutant allowed us to clarify the importance of PLC activation for ET A -mediated cellular effects of endothelins such as arachidonic acid release and mitogenic activity. The failure of ET A -1215S/A to induce release of arachidonic acid in CHO cells strongly suggests that this signal transduction pathway requires phosphatidylinositol hydrolysis and/or a transient increase in [Ca 2ϩ ] i for cPLA 2 activation to occur (41) whereas stimulation of adenylyl cyclase alone is insufficient to produce the arachidonic acid release. The discrepancies between our present data in CHO cells frequently used to analyze the signal transduction pathways of G protein-coupled receptors (10, 42) , and those of earlier reports stating that endothelin-mediated arachidonic acid release is independent of phosphatidylinositol hydrolysis and [Ca 2ϩ ] i transient in smooth muscle cells (16, 17) might reflect cell-type specific differences in signal transduction pathways. In Swiss 3T3 and artery smooth muscle cells, ET-1 stimulates adenylyl cyclase and PLC and acts as a powerful mitogen (34, 43) . Because activation of each of these signal transduction pathways could be a trigger for promoting DNA synthesis it is still unclear how they specifically contribute to the mitogenic action of ET A . Our data with the mutant ET A -1215S show that ET-1-induced adenylyl cyclase activation alone is insufficient to promote the mitogenic stimulus seen with the wild type ET A . Therefore PLC stimulation by ET A is likely to be required for the observed mitogenic activity of ET-1. On the other hand inhibition of growth factor-stimulated [ 3 H]thymidine incorporation by ET A -1215S is unaffected by the loss of ET A palmitoylation (see above) suggesting that the mitogenic activity and the inhibitory activity of ET A are effected by distinct mechanisms. Phosphorylation of the epidermal growth factor receptor seems to be required for ET A -mediated mitogenicity in Rat-1 cells (44) . It will be interesting to analyze whether the non-palmitoylated ET A is able to induce the phosphorylation of the epidermal growth factor receptor. We anticipate that the non-palmitoylated ET A receptor will be a useful tool to elucidate important steps in the endothelinmediated signaling cascades.
